Candel Appoints Regulatory Leader Zimmermann to Board
Candel Therapeutics announced the appointment of Martine Zimmermann to its board of directors. Her addition strengthens the company's leadership ahead of expected regulatory filings and commercial growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day